I am curious what everybody thinks about Boston Scientific (BSX). They are going to be announcing sometime this week (was supposed to be as early as monday) the approval of their drug coated stent. I have read many reports saying this will generate between 1.3-1.7 bln in revenue in 2004 alone. The stent is supposed to swallow up 50% of the market...the top execs are talking about a percentage in the 70's.
The main competition is JNJ and GDT whom have teamed up to market JNJ's stent. However, from the reports I have read, BSX's stent is supposed preferred by physicians.
I am planning on getting into this stock tomorrow before it moves.